NCT06729450View on ClinicalTrials.gov

Efficacy and Tolerability of DispersinB Acne Cleanser in the Treatment of Mild to Moderate Acne Vulgaris

NANot yet recruitingINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

January 30, 2026

Primary Completion Date

October 31, 2026

Study Completion Date

December 16, 2026

Conditions

Acne Vulgaris on the Face

Interventions

DEVICE

DispersinB Acne Cleanser

DispersinB Acne Cleanser, strength: 80 ug/g, topical gel

Trial Locations (1)

33124

University of Miami, Miami

Sponsors

Lead Sponsor

Kane Biotech Inc

All Listed Sponsors

collaborator

University of Miami

OTHER

lead

Kane Biotech Inc

INDUSTRY

NCT06729450 - Efficacy and Tolerability of DispersinB Acne Cleanser in the Treatment of Mild to Moderate Acne Vulgaris | Biotech Hunter | Biotech Hunter